nsc 30705 has been researched along with Leukemia L 1210 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Driscoll, JS; Khan, AH | 1 |
| de Boer, M; Driebergen, RJ; Hilbers, HW; Holthuis, JJ; Janssen, LH; Moret, EE; Reinhoudt, DN; Tollenaere, JP; Verboom, W | 1 |
2 other study(ies) available for nsc 30705 and Leukemia L 1210
| Article | Year |
|---|---|
Potential central nervous system antitumor agents. Aziridinylbenzoquinones. 1.
Topics: Animals; Antineoplastic Agents; Aziridines; Brain Neoplasms; Central Nervous System; Ependymoma; Leukemia L1210; Leukemia, Experimental; Lung Neoplasms; Melanoma; Mice; Neoplasms, Experimental; Quinones | 1976 |
In vivo activity and hydrophobicity of cytostatic aziridinyl quinones.
Topics: Animals; Antineoplastic Agents; Benzoquinones; Leukemia L1210; Melanoma, Experimental; Mice | 1996 |